Park CY

References (3)

Title : A functional genomic framework to elucidate novel causal metabolic dysfunction-associated fatty liver disease genes - Saliba-Gustafsson_2025_Hepatology_82_165
Author(s) : Saliba-Gustafsson P , Justesen JM , Ranta A , Sharma D , Bielczyk-Maczynska E , Li J , Najmi LA , Apodaka M , Aspichueta P , Bjorck HM , Eriksson P , Schurr TM , Franco-Cereceda A , Gloudemans M , Mujica E , den Hoed M , Assimes TL , Quertermous T , Carcamo-Orive I , Park CY , Knowles JW
Ref : Hepatology , 82 :165 , 2025
Abstract :
PubMedSearch : Saliba-Gustafsson_2025_Hepatology_82_165
PubMedID: 39190705
Gene_locus related to this paper: human-LYPLAL1

Title : Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy - Song_2023_Mol.Metab__101806
Author(s) : Song Y , Yang H , Kim J , Lee Y , Kim SH , Do IG , Park CY
Ref : Mol Metab , :101806 , 2023
Abstract :
PubMedSearch : Song_2023_Mol.Metab__101806
PubMedID: 37739179

Title : Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extension - Hong_2017_Diabetes.Obes.Metab_19_654
Author(s) : Hong SM , Park CY , Hwang DM , Han KA , Lee CB , Chung CH , Yoon KH , Mok JO , Park KS , Park SW
Ref : Diabetes Obes Metab , 19 :654 , 2017
Abstract :
PubMedSearch : Hong_2017_Diabetes.Obes.Metab_19_654
PubMedID: 28058750